NR1H4 and metabolic syndrome: Because FXR gene ablations promotes a pro-atherogenic lipid profile and FXR ligands rescue from dyslipidemia in rodents, we have investigated whether FXR agonism attenuates dyslipidemia caused by ritonavir a widely used HIV-PI in mice.